Stay updated on NYX-2925 Efficacy & Safety in DPN Clinical Trial
Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.

Latest updates to the NYX-2925 Efficacy & Safety in DPN Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new site revision banner (v3.4.2) and removes an outdated funding-status notice (v3.4.1); these are minor UI updates that do not alter the study information.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH Clinical Center status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedMinor UI and copy updates: shows a glossary toggle, capitalization tweaks (No FEAR Act Data; Last Update Submitted that Met QC Criteria), and a new revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section listing study sites across AZ, CA, CT, FL, GA, ID, IL, MO, NJ, NY, OH, TN, TX, and VA, and removed several state-specific location subsections and the HHS Vulnerability Disclosure.SummaryDifference1%

- Check92 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to NYX-2925 Efficacy & Safety in DPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in DPN Clinical Trial page.